Edgestream Partners, L.P.

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1535061 Princeton, NJ

Position in ACAD

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$7,167,515

+$2,908,554 QoQ

Shares Held

283,301

+48.1% QoQ

Ownership

0.164%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#59

of 352 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Edgestream Partners, L.P. holds $89,105,792 across 25 Biotechnology names. ACAD ranks #3 (8.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PCVX	Vaxcyte, Inc.	131,115	$7,621,714
2	EXEL	Exelixis, Inc.	132,163	$7,190,988
3	ACAD	Acadia Pharmaceuticals Inc This page	283,301	$7,167,515
4	HRMY	Harmony Biosciences Holdings, Inc.	183,501	$6,681,271
5	INVA	Innoviva, Inc.	269,348	$6,116,893
6	BMRN	Biomarin Pharmaceutical Inc	100,897	$5,773,326
7	NVAX	Novavax Inc	559,796	$5,273,278
8	IONS	Ionis Pharmaceuticals Inc	56,715	$4,496,932

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,167,515	283,301	+48.1%	Shares	Sole	2026-08-11
2026-03-31	$4,258,961	191,328	-39.5%	Shares	Sole	2026-05-18
2025-12-31	$8,446,743	316,239	+35.2%	Shares	Sole	2026-02-13
2025-09-30	$4,990,252	233,845	+110.4%	Shares	Sole	2025-11-12
2025-06-30	$2,397,376	111,144	-30.1%	Shares	Sole	2025-08-13
2025-03-31	$2,642,783	159,108	-39.8%	Shares	Sole	2025-05-02
2024-12-31	$4,851,556	264,390	+20.5%	Shares	Sole	2025-02-07
2024-09-30	$3,373,280	219,329	+141.1%	Shares	Sole	2024-11-14
2024-06-30	$1,478,051	90,957	+46.9%	Shares	Sole	2024-08-09
2024-03-31	$1,144,641	61,906	+63.3%	Shares	Sole	2024-05-10
2023-12-31	$1,186,899	37,908	+290.7%	Shares	Sole	2024-02-14
2023-09-30	$202,210	9,703	-88.5%	Shares	Sole	2023-11-15
2023-06-30	$2,015,871	84,170	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.